190 related articles for article (PubMed ID: 23205080)
1. Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.
Ditsch N; Mayr D; Lenhard M; Strauss C; Vodermaier A; Gallwas J; Stoeckl D; Graeser M; Weissenbacher T; Friese K; Jeschke U
Oncol Lett; 2012 Oct; 4(4):665-671. PubMed ID: 23205080
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.
Juge-Aubry CE; Gorla-Bajszczak A; Pernin A; Lemberger T; Wahli W; Burger AG; Meier CA
J Biol Chem; 1995 Jul; 270(30):18117-22. PubMed ID: 7629123
[TBL] [Abstract][Full Text] [Related]
4. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
Buroker NE; Barboza J; Huang JY
FEBS J; 2009 Jun; 276(12):3247-55. PubMed ID: 19438714
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of peroxisome proliferator signaling pathways by thyroid hormone receptor. Competitive binding to the response element.
Miyamoto T; Kaneko A; Kakizawa T; Yajima H; Kamijo K; Sekine R; Hiramatsu K; Nishii Y; Hashimoto T; Hashizume K
J Biol Chem; 1997 Mar; 272(12):7752-8. PubMed ID: 9065436
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes.
Hunter J; Kassam A; Winrow CJ; Rachubinski RA; Capone JP
Mol Cell Endocrinol; 1996 Feb; 116(2):213-21. PubMed ID: 8647322
[TBL] [Abstract][Full Text] [Related]
7. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter.
Palmer CN; Hsu MH; Muerhoff AS; Griffin KJ; Johnson EF
J Biol Chem; 1994 Jul; 269(27):18083-9. PubMed ID: 8027069
[TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.
Chu R; Madison LD; Lin Y; Kopp P; Rao MS; Jameson JL; Reddy JK
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11593-7. PubMed ID: 8524810
[TBL] [Abstract][Full Text] [Related]
12. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas.
Takiyama Y; Miyokawa N; Sugawara A; Kato S; Ito K; Sato K; Oikawa K; Kobayashi H; Kimura S; Tateno M
J Clin Endocrinol Metab; 2004 Nov; 89(11):5851-61. PubMed ID: 15531552
[TBL] [Abstract][Full Text] [Related]
14. Retinoid X Receptor Selective Agonists and their Synthetic Methods.
Wagner CE; Jurutka PW; Marshall PA; Heck MC
Curr Top Med Chem; 2017; 17(6):742-767. PubMed ID: 27320333
[TBL] [Abstract][Full Text] [Related]
15. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element.
IJpenberg A; Jeannin E; Wahli W; Desvergne B
J Biol Chem; 1997 Aug; 272(32):20108-17. PubMed ID: 9242684
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 Breast Cancer Cells.
Nehdi A; Ali R; Alhallaj A; Alzahrani H; Samman N; Mashhour A; Baz O; Barhoumi T; Alghanem B; Khan A; Alriyees L; Boudjelal M
Molecules; 2019 May; 24(11):. PubMed ID: 31141879
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptors.
Rowe A
Int J Biochem Cell Biol; 1997 Feb; 29(2):275-8. PubMed ID: 9147128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]